PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | +200.0% | 57,659 | +182.6% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 20,402 | -52.2% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 42,659 | +90.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 22,457 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 22,457 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | +100.0% | 22,457 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 22,457 | +3.7% | 0.00% | – |
Q2 2020 | $1,000 | – | 21,657 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $8,500 | 0.00% |
LEE DANNER & BASS INC | 50,000 | $4 | 0.00% |
LBMC INVESTMENT ADVISORS, LLC | 22,000 | $1,716 | 0.00% |
Atlas Wealth LLC | 26,620 | $2,249 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,690 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |